Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ContraVir Pharmaceuticals Inc (NASDAQ:CTRV)

2.01
Delayed Data
As of Dec 08
 +0.02 / +1.01%
Today’s Change
0.76
Today|||52-Week Range
2.65
+30.52%
Year-to-Date
Biotechs Bolstered on 21st Century Cures Passage
Dec 08 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close1.99
Today’s open2.10
Day’s range1.95 - 2.14
Volume2,530,859
Average volume (3 months)1,313,528
Market cap$120.5M
Dividend yield--
Data as of 12/08/2016

Growth & Valuation

Earnings growth (last year)+38.24%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SMMTSummit Therapeutics ...-0.21-2.06%
ECYTEndocyte Inc+0.02+0.73%
FBIOFortress Biotech Inc0.000.00%
MSLIMerus Labs Internati...+0.00+0.31%
Data as of 12/08/2016

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$0.00
Annual profit (last year)-$17.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
James E. Sapirstein
Chief Financial Officer
John T. Cavan
Corporate headquarters
Edison, New Jersey

Forecasts


Search for Jobs